Mumbai
₹ 13,835 /gm
Henri Beaufour, heir to the Ipsen Group legacy, was born in Neuilly-sur-Seine, France, in 1965. Educated at Georgetown University, Beaufour inherited a significant portion of his family's wealth, controlling 57% of Ipsen Group with his sister Anne. As key figures on Ipsen's Board and Mayroy's holding company, the siblings oversee a €3 billion fortune. This insight is essential for finance readers tracking industry magnates and heritage corporations.
June 01, 1965
Pharmaceuticals
Healthcare
France
London
Albert Beaufour
Henri Beaufour was born on January 6, 1965, in Neuilly-sur-Seine, France. He is the son of Albert Beaufour and the grandson of Dr. Henri Beaufour, the founder of the Ipsen Group, a global pharmaceutical company.
Henri Beaufour: Family
Henri Beaufour comes from a prominent French family with a long history in the pharmaceutical industry. His father, Albert Beaufour, was a successful businessman who served as the CEO of Ipsen Group. Henri's sister, Anne Beaufour, is also involved in the family business and holds a significant stake in Ipsen.
Henri Beaufour: Career Highlights
Henri Beaufour began his career in the pharmaceutical industry after graduating from Georgetown University with a bachelor's of arts degree. He joined Ipsen Group and quickly rose through the ranks, holding various leadership positions. In 2000, following the death of his father, Henri inherited 76% of the family's capital in Ipsen, making him the majority shareholder.
Henri Beaufour: Companies
Henri Beaufour is primarily associated with Ipsen Group, the global pharmaceutical company founded by his grandfather. He currently serves on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company. Under his leadership, Ipsen has experienced significant growth and success, becoming a leading player in the pharmaceutical industry.
Henri Beaufour: Major Achievements
One of Henri Beaufour's major achievements is his successful stewardship of Ipsen Group. Under his leadership, the company has expanded its global reach, developed innovative drugs, and achieved strong financial performance. Henri is also credited with diversifying Ipsen's portfolio and driving its growth in key therapeutic areas.
Henri Beaufour: Awards & Achievements
Henri Beaufour's contributions to the pharmaceutical industry have been recognized through numerous awards and accolades. He has been honored for his leadership, innovation, and commitment to improving patient lives. Some of his notable awards include the Chevalier de la Légion d'Honneur, one of France's highest civilian honors.
Henri Beaufour: Personal Life & Legacy
Henri Beaufour is known for his philanthropic efforts and support of various charitable causes.
He is actively involved in initiatives related to healthcare, education, and social welfare. Henri Beaufour's legacy is one of innovation, entrepreneurship, and a commitment to making a positive impact on society.
Henri Beaufour: Trivia
Henri Beaufour is a passionate art collector and has a keen interest in contemporary art. He is also an avid traveler and enjoys exploring different cultures and cuisines.
Henri Beaufour is born in Neuilly-sur-Seine, France.
Henri Beaufour inherits 76% of the family's capital in Ipsen after his father's death.
Henri Beaufour's estimated fortune is Euro 3 billion.
What is Henri Beaufour's net worth?
What are Henri Beaufour's main sources of wealth?
In which industry does Henri Beaufour primarily operate?
Who is Henri Beaufour and how is he related to Ipsen Group?
How did Henri Beaufour acquire his share in Ipsen Group?
What percentage of Ipsen Group does Henri Beaufour control?
What are Henri Beaufour's educational credentials?